A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This open-label, 2-arm study will compare the pharmacokinetics of CellCept and mycophenolate
sodium in kidney transplanted patients on a calcineurininhibitor-free mycophenolic acid-based
therapy. On the study day patients will take their prescribed medication (either CellCept or
mycophenolate sodium). Blood samples will be drawn directly before and at intervals up to 12
hours after intake of the study medication. Anticipated time on study treatment is 12 hours
and target sample size is 24.